Zhejiang Sanmei Chemical Industry Co., Ltd.
SSE:603379.SS
44.6 (CNY) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,333.788 | 4,770.651 | 4,048.446 | 2,720.728 | 3,934.603 | 4,454.332 | 3,899.482 | 2,700.265 | 2,280.843 | 2,136.261 | 1,906.663 |
| Cost of Revenue
| 2,886.898 | 4,004.177 | 3,110.173 | 2,309.665 | 2,762.887 | 2,690.874 | 2,268.926 | 1,747.214 | 1,695.988 | 1,679.689 | 1,472.96 |
| Gross Profit
| 446.89 | 766.474 | 938.273 | 411.063 | 1,171.715 | 1,763.458 | 1,630.556 | 953.051 | 584.855 | 456.572 | 433.703 |
| Gross Profit Ratio
| 0.134 | 0.161 | 0.232 | 0.151 | 0.298 | 0.396 | 0.418 | 0.353 | 0.256 | 0.214 | 0.227 |
| Reseach & Development Expenses
| 53.058 | 38.311 | 26.824 | 25.25 | 23.07 | 24.047 | 22.226 | 12.363 | 3.68 | 0 | 0 |
| General & Administrative Expenses
| 64.869 | 71.71 | 38.268 | 28.805 | 39.9 | 30.757 | 25.227 | 104.976 | 82.714 | 82.169 | 99.064 |
| Selling & Marketing Expenses
| 36.244 | 64.661 | 61.494 | 49.159 | 239.842 | 237.143 | 209.272 | 153.459 | 130.333 | 131.432 | 124.791 |
| SG&A
| 101.114 | 136.371 | 99.762 | 77.964 | 279.742 | 267.9 | 234.499 | 258.435 | 213.048 | 213.601 | 223.855 |
| Other Expenses
| -5.957 | 98.588 | 90.741 | 70.908 | 83.389 | 22.357 | 6.13 | 11.508 | 4.631 | 4.768 | 10.28 |
| Operating Expenses
| 147.114 | 273.27 | 217.327 | 174.122 | 386.201 | 390.872 | 350.143 | 358.17 | 231.131 | 237.648 | 252.617 |
| Operating Income
| 298.675 | 647.474 | 712.817 | 284.78 | 822.406 | 1,402.622 | 1,235.158 | 514.892 | 270.169 | 189.33 | 76.756 |
| Operating Income Ratio
| 0.09 | 0.136 | 0.176 | 0.105 | 0.209 | 0.315 | 0.317 | 0.191 | 0.118 | 0.089 | 0.04 |
| Total Other Income Expenses Net
| 76.752 | -4.232 | -9.454 | 9.862 | 5.803 | 22.012 | 6.474 | 9.818 | 4.631 | 4.65 | 8.735 |
| Income Before Tax
| 375.427 | 643.242 | 703.362 | 294.642 | 828.21 | 1,424.634 | 1,241.632 | 524.71 | 274.8 | 193.98 | 85.492 |
| Income Before Tax Ratio
| 0.113 | 0.135 | 0.174 | 0.108 | 0.21 | 0.32 | 0.318 | 0.194 | 0.12 | 0.091 | 0.045 |
| Income Tax Expense
| 95.782 | 157.669 | 167.194 | 73.069 | 182.912 | 316.27 | 286.264 | 160.004 | 64.773 | 47.433 | 23.512 |
| Net Income
| 279.645 | 485.573 | 536.169 | 221.846 | 645.907 | 1,107.714 | 954.167 | 364.281 | 209.589 | 146.82 | 63.691 |
| Net Income Ratio
| 0.084 | 0.102 | 0.132 | 0.082 | 0.164 | 0.249 | 0.245 | 0.135 | 0.092 | 0.069 | 0.033 |
| EPS
| 0.46 | 0.8 | 0.88 | 0.36 | 1.06 | 2.1 | 1.81 | 0.69 | 0.4 | 0.59 | 0.26 |
| EPS Diluted
| 0.46 | 0.8 | 0.88 | 0.36 | 1.06 | 2.1 | 1.81 | 0.69 | 0.4 | 0.59 | 0.26 |
| EBITDA
| 514.864 | 757.272 | 820.499 | 401.391 | 930.625 | 1,499.515 | 1,269.79 | 568.147 | 341.133 | 218.924 | 181.086 |
| EBITDA Ratio
| 0.154 | 0.159 | 0.203 | 0.148 | 0.237 | 0.337 | 0.326 | 0.21 | 0.15 | 0.102 | 0.095 |